Suppr超能文献

急诊科鼻咽拭子中 SARS-CoV-2 病毒载量不能预测 COVID-19 的严重程度和死亡率。

SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality.

机构信息

Emergency Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

INSERM (French National Institute of Health and Medical Research, UMR 1260, Regenerative NanoMedicine (RNM), Fédération de Médecine Translationnelle (FMTS), University of Strasbourg, Strasbourg, France.

出版信息

Acad Emerg Med. 2021 Mar;28(3):306-313. doi: 10.1111/acem.14217. Epub 2021 Feb 5.

Abstract

INTRODUCTION

The ongoing COVID-19 pandemic has led to devastating repercussions on health care systems worldwide. This viral infection has a broad clinical spectrum (ranging from influenza-like disease, viral pneumonia, and hypoxemia to acute respiratory distress syndrome requiring prolonged intensive care unit stays). The prognostic impact of measuring viral load on nasopharyngeal swab specimens (by reverse transcriptase polymerase chain reaction [RT-PCR]) is yet to be elucidated.

METHODS

Between March 3 and April 5, 2020, we conducted a retrospective study on a cohort of COVID-19 patients (mild or severe disease) who were hospitalized after presenting to the emergency department (ED) and had at least one positive nasopharyngeal swab during their hospital stay. We led our study at the University Hospitals of Strasbourg in the Greater East region of France, one of the pandemic's epicenters in Europe.

RESULTS

We have collected samples from a cohort of 287 patients with a confirmed diagnosis of COVID-19 who were included in our study. Nearly half of them (50.5%) presented a mild form of the disease, while the other half (49.5%) presented a severe form, requiring mechanical ventilation. Median (interquartile range) viral load on the initial upper respiratory swab at admission was 4.76 (3.29-6.06) log copies/reaction. When comparing survivors and nonsurvivors, this viral load measurement did not differ according to subgroups (p = 0.332). Additionally, we have found that respiratory viral load measurement was predictive of neither in-hospital mortality (adjusted odds ratio [AOR] = 1.05, 95% confidence interval [CI] = 0.85 to 1.31, p = 0.637) nor disease severity (AOR = 0.88, 95% CI = 0.73 to 1.06, p = 0.167).

CONCLUSION

Respiratory viral load measurement on the first nasopharyngeal swab (by RT-PCR) during initial ED management is neither a predictor of severity nor a predictor of mortality in SARS-CoV-2 infection. Host response to this viral infection along with the extent of preexisting comorbidities might be more foretelling of disease severity than the virus itself.

摘要

引言

持续的 COVID-19 大流行对全球的医疗体系造成了毁灭性的影响。这种病毒感染具有广泛的临床谱(从流感样疾病、病毒性肺炎和低氧血症到需要长时间重症监护病房治疗的急性呼吸窘迫综合征)。通过逆转录聚合酶链反应(RT-PCR)测量鼻咽拭子标本中的病毒载量的预后影响尚未阐明。

方法

2020 年 3 月 3 日至 4 月 5 日,我们对一组在急诊科就诊后住院的 COVID-19 患者(轻症或重症)进行了回顾性研究,这些患者在住院期间至少有一次鼻咽拭子检测结果为阳性。我们在法国大东部地区斯特拉斯堡大学附属医院进行了这项研究,该地区是欧洲大流行的中心之一。

结果

我们收集了 287 例确诊为 COVID-19 的患者的样本,这些患者均纳入了我们的研究。其中近一半(50.5%)患者表现为轻症,另一半(49.5%)患者表现为重症,需要机械通气。入院时初始上呼吸道拭子的中位(四分位距)病毒载量为 4.76(3.29-6.06)log 拷贝/反应。在比较幸存者和非幸存者时,根据亚组(p=0.332),病毒载量测量结果无差异。此外,我们发现,呼吸病毒载量测量既不能预测院内死亡率(调整后的优势比 [AOR]=1.05,95%置信区间 [CI]0.85-1.31,p=0.637),也不能预测疾病严重程度(AOR=0.88,95%CI=0.73-1.06,p=0.167)。

结论

在急诊初始管理期间进行的第一次鼻咽拭子(通过 RT-PCR)的呼吸病毒载量测量既不是 SARS-CoV-2 感染严重程度的预测因素,也不是死亡率的预测因素。宿主对这种病毒感染的反应以及预先存在的合并症的严重程度可能比病毒本身更能预示疾病的严重程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验